Table 1.
Rank | Journal | Counts (%) | IF (2021) | JCR | Country | Rank | Co-cited Journal | Counts (%) | IF (2021) | JCR | Country |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Frontiers in Immunology | 252(4.21) | 7.561 | Q2 | Switzerland | 1 | Blood | 37798 (8.15) | 22.113 | Q1 | US |
2 | Cancers | 155(2.59) | 6.639 | Q2 | Switzerland | 2 | New England Journal of Medicine | 16573 (3.57) | 91.245 | Q1 | US |
3 | Molecular Therapy | 130(2.17) | 11.454 | Q1 | US | 3 | Clinical Cancer Research | 15154 (3.26) | 12.531 | Q1 | US |
4 | Blood | 127(2.12) | 22.113 | Q1 | US | 4 | Journal of Immunology | 13870 (2.99) | 5.422 | Q2 | US |
5 | Clinical Cancer Research | 111(1.85) | 12.531 | Q1 | US | 5 | Cancer Research | 13614 (2.93) | 12.701 | Q1 | US |
6 | Journal for Immunotherapy of Cancer | 111(1.85) | 13.751 | Q3 | UK | 6 | Journal of Clinical Oncology | 13454 (2.90) | 44.544 | Q1 | US |
7 | International Journal of Molecular Sciences | 99(1.65) | 5.923 | Q2 | US | 7 | Molecular Therapy | 10809 (2.33) | 11.454 | Q1 | US |
8 | Oncoimmunology | 98(1.63) | 8.110 | Q1 | US | 8 | Proceedings of the National Academy of Sciences of the United States of America | 10597 (2.28) | 11.205 | Q1 | US |
9 | Cancer Research | 96(1.60) | 12.701 | Q1 | US | 9 | Science | 8492 (1.83) | 47.728 | Q1 | US |
10 | Frontiers In Oncology | 93(1.55) | 6.244 | Q2 | US | 10 | Nature Medicine | 8465 (1.82) | 53.440 | Q1 | US |
IF, impact factor; JCR, journal citation reports; US, The United States; UK, The United Kingdom.